Creative Planning’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
78,470
+39,491
| +101% | +$1.28M | ﹤0.01% | 1142 |
|
|
2025
Q1 | $1.47M | Sell |
38,979
-7,842
| -17% | -$296K | ﹤0.01% | 1409 |
|
|
2024
Q4 | $3.83M | Buy |
46,821
+9,296
| +25% | +$761K | ﹤0.01% | 771 |
|
|
2024
Q3 | $4.29M | Buy |
37,525
+10,245
| +38% | +$1.17M | ﹤0.01% | 692 |
|
|
2024
Q2 | $2.06M | Buy |
27,280
+10,642
| +64% | +$804K | ﹤0.01% | 968 |
|
|
2024
Q1 | $1.14M | Buy |
16,638
+4,688
| +39% | +$320K | ﹤0.01% | 1250 |
|
|
2023
Q4 | $750K | Buy |
11,950
+2,875
| +32% | +$181K | ﹤0.01% | 1422 |
|
|
2023
Q3 | $463K | Buy |
9,075
+2,634
| +41% | +$134K | ﹤0.01% | 1612 |
|
|
2023
Q2 | $322K | Buy |
+6,441
| New | +$322K | ﹤0.01% | 1849 |
|
|
2023
Q1 | – | Sell |
-4,269
| Closed | -$205K | – | 2617 |
|
|
2022
Q4 | $205K | Buy |
+4,269
| New | +$205K | ﹤0.01% | 1995 |
|